help button home button Endocrine Society Endocrinology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH

This version published online on September 11, 2003
Endocrinology, doi:10.1210/en.2003-0986
A more recent version of this article appeared on December 1, 2003
This Article
Right arrow Author Manuscript (PDF)
Right arrow All Versions of this Article:
144/12/5322    most recent
Author Manuscript (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Perchick, G. B
Right arrow Articles by Jabbour, H. N
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Perchick, G. B
Right arrow Articles by Jabbour, H. N

Submitted on August 1, 2003
Accepted on August 29, 2003

COX-2 overexpression inhibits cathepsin D mediated cleavage of plasminogen to the potent anti-angiogenic factor angiostatin

Gabrielle B Perchick1 and Henry N Jabbour1*

1 MRC Human Reproductive Sciences Unit, Centre for Reproductive Biology, The University of Edinburgh Academic Centre, Chancellor's Building, 49 Little France Crescent, Edinburgh EH16 4SB, United Kingdom

* To whom correspondence should be addressed. E-mail: h.jabbour{at}hrsu.mrc.ac.uk.

Overexpression of COX-2 and enhanced synthesis of PGE2 have been implicated in human endometrial pathologies. To investigate the molecular role of COX-2, the Ishikawa human endometrial epithelial cell line was stably transfected with the pIRES2 vector containing COX-2 cDNA in either the sense or antisense directions. PGE2 concentrations were significantly elevated in the cells transfected with the COX-2 sense compared with wild-type cells or cells transfected with the antisense cDNA (P < 0.01). Elevated PGE2 synthesis was associated with enhanced expression and signaling of EP receptors. cDNA array analysis revealed differential expression of cathepsin D between the COX-2 sense and antisense cells. Cathepsin D RNA and protein expression was 6.7 and 2.1 fold lower in the COX-2 sense compared with COX-2 antisense cells respectively. Cathepsin D is known to cleave plasminogen to the potent anti-angiogenic factor angiostatin. To investigate differential angiostatin generation, conditioned media from COX-2 sense, COX-2 antisense and wild-type cells were incubated with plasminogen and subsequently subjected to Western blot analysis. In comparison to wild-type cells, the cleavage of plasminogen to angiostatin was abolished when incubated in COX-2 sense cells conditioned media and elevated when incubated in COX-2 antisense cells conditioned media. Co-incubation of plasminogen with the cathepsin D inhibitor Pepstatin A inhibited the cleavage of plasminogen to angiostatin in the COX-2 antisense conditioned media. These data demonstrate that COX-2 exerts a negative feedback on the expression of cathepsin D. This in turn reduces the generation of the anti-angiogenic factor angiostatin, hence promoting a pro-angiogenic environment.


Key words: COX-2 • Ishikawa • angiostatin • cathepsin D • EP receptors







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 2003 by The Endocrine Society